Jointly reconstructing ground motion and resistivity for ERT-based slope stability monitoring

Electrical resistivity tomography (ERT) is increasingly being used to investigate unstable slopes and monitor the hydrogeological processes within. But movement of electrodes or incorrect placement of electrodes with respect to an assumed model can introduce significant resistivity artefacts into the reconstruction. In this work, we demonstrate a joint resistivity and electrode movement reconstruction algorithm within an iterative Gauss–Newton framework. We apply this to ERT monitoring data from an active slow-moving landslide in the UK. Results show fewer resistivity artefacts and suggest that electrode movement and resistivity can be reconstructed at the same time under certain conditions. A new 2.5-D formulation for the electrode position Jacobian is developed and is shown to give accurate numerical solutions when compared to the adjoint method on 3-D models. On large finite element meshes, the calculation time of the newly developed approach was also proven to be orders of magnitude faster than the 3-D adjoint method and addressed modelling errors in the 2-D perturbation and adjoint electrode position Jacobian

Monitoring Steam-Assisted Gravity Drainage (SAGD) with EIT

Steam-assisted gravity drainage (SAGD) is a technique that has been developed to efficiently extract bitumen from deep reservoirs. We propose using electrical impedance tomography (EIT) for real-time monitoring of SAGD wells to maintain optimal operating conditions. Several electrode configurations along the pipelines and measurement strategies are presented and compared

Slope Stability Monitoring through Impedance Imaging

A technique for monitoring slope stability in a geological setting through impedance tomography is demonstrated. An iterative absolute Gauss-Newton solver simultaneously constructs estimates of the underground resistivity distribution and movement of the stimulation and measurement electrodes. The results are a step toward demonstrating that a cost effective and potentially predictive monitoring technology could be practica

Editorial Introduction to ‘Paddison Geographies’

Reflecting biographical entanglements at varying points in both their and Ronan’s lives and careers, the contributors bear witness to Ronan’s expansive intellect and the thematic, conceptual, disciplinary, methodological and geographical breadth of his research concerns. We can learn much from studying an academic life, and especially one as rich and prodigious as Ronan’s. And yet, as academics, we do so little of this kind of labour, depriving ourselves of repositories of vital wisdom and knowledge and wastefully neglecting hard won intellectual resources. In Ronan’s scholarly corpus, there is much to excavate, reappraise, and appreciate. But this Editorial Introduction to ‘Paddison Geographies’ will not revisit Ronan’s research, teaching, and service – this task is performed with authority, empathy, wisdom and verve in the formal introduction to the Special Issue written by Chris Philo and thereafter in the articles which follow

Open Electrical Impedance Tomography (OEIT) File Format

Electrical impedance tomography (EIT) creates tomographic images from surface electrical stimulation and measurement. Many research and commercial devices have been made, with correspondingly many data formats, which negatively impacts the ability to share data. To address this issue, we have developed the OEIT data format, an XMLbased flexible container format for EIT data. We describe its features and structure

Localization and chiral symmetry in 2+1 flavor domain wall QCD

We present results for the dependence of the residual mass of domain wall fermions (DWF) on the size of the fifth dimension and its relation to the density and localization properties of low-lying eigenvectors of the corresponding hermitian Wilson Dirac operator relevant to simulations of 2+1 flavor domain wall QCD. Using the DBW2 and Iwasaki gauge actions, we generate ensembles of configurations with a $16^3\times 32$ space-time volume and an extent of 8 in the fifth dimension for the sea quarks. We demonstrate the existence of a regime where the degree of locality, the size of chiral symmetry breaking and the rate of topology change can be acceptable for inverse lattice spacings $a^{-1} \ge 1.6$ GeV.Comment: 59 Pages, 23 figures, 1 MPG linke

Juvenile Paget’s disease with compound heterozygous mutations in TNFRSF11B presenting with recurrent clavicular fractures and a mild skeletal phenotype

Juvenile Paget’s disease (JPD) is a rare recessively-inherited bone dysplasia. The great majority of cases described to date have had homozygous mutations in TNFRSF11B, the gene encoding osteoprotegerin. We describe a boy who presented with recurrent clavicular fractures following minor trauma (8 fractures from age 2 to 11). He was of normal height and despite mild lateral bowing of the thighs and anterior bowing of the shins he remained physically active. Abnormal modelling was noted in ribs and humeri on clavicular radiographs, and a skeletal survey at the age of 7 showed generalised diaphyseal expansion of the long bones with thickening of the periosteal and endosteal surfaces of the cortices. On biochemical evaluation, serum alkaline phosphatase was noted to be persistently elevated. The diagnosis of JPD was confirmed by the finding of compound heterozygous mutations in TNFRSF11B: a maternally-inherited A > G missense mutation at position 1 of the first amino acid codon (previously reported) and a paternally-inherited splice acceptor site mutation in intron 3 at a highly conserved position (not previously reported). Bioinformatics analysis suggested both mutations were disease-causing. Compound heterozygote mutations in TNFRSF11B causing JPD have been previously reported only once – in a boy who also had a relatively mild skeletal phenotype. The milder features may lead to delay in diagnosis and diagnostic confusion with other entities, but the extraskeletal features of JPD may nonetheless develop

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis:a protocol for the CLEAR clinical trial

Background: Current guidelines for the management of bronchiectasis (BE) highlight the lack of evidence to recommend mucoactive agents, such as hypertonic saline (HTS) and carbocisteine, to aid sputum removal as part of standard care. We hypothesise that mucoactive agents (HTS or carbocisteine, or a combination) are effective in reducing exacerbations over a 52-week period, compared to usual care. Methods: This is a 52-week, 2 × 2 factorial, randomized, open-label trial to determine the clinical effectiveness and cost effectiveness of HTS 6% and carbocisteine for airway clearance versus usual care-the Clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care (CLEAR) trial. Patients will be randomised to (1) standard care and twice-daily nebulised HTS (6%), (2) standard care and carbocisteine (750 mg three times per day until visit 3, reducing to 750 mg twice per day), (3) standard care and combination of twice-daily nebulised HTS and carbocisteine, or (4) standard care. The primary outcome is the mean number of exacerbations over 52 weeks. Key inclusion criteria are as follows: Adults with a diagnosis of BE on computed tomography, BE as the primary respiratory diagnosis, and two or more pulmonary exacerbations in the last year requiring antibiotics and production of daily sputum. Discussion: This trial's pragmatic research design avoids the significant costs associated with double-blind trials whilst optimising rigour in other areas of trial delivery. The CLEAR trial will provide evidence as to whether HTS, carbocisteine or both are effective and cost effective for patients with BE. Trial registration: EudraCT number: 2017-000664-14 (first entered in the database on 20 October 2017). ISRCTN.com, ISRCTN89040295. Registered on 6 July/2018. Funder: National Institute for Health Research, Health Technology Assessment Programme (15/100/01). Sponsor: Belfast Health and Social Care Trust. Ethics Reference Number: 17/NE/0339. Protocol version: V3.0 Final_14052018